EMEA-001944-PIP01-16-M03
Key facts
| Active substance |
Vadadustat
|
| Therapeutic area |
Haematology-Hemostaseology
|
| Decision number |
P/0244/2022
|
| PIP number |
EMEA-001944-PIP01-16-M03
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of anaemia due to chronic disorders
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Akebia Europe Limited
E-mail: info@akebia.com Tel. +1 6178712098 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|